Methotrexate Orion Pharma

Methotrexate, the active ingredient in Methotrexate Orion Pharma, is an antimetabolite immunosuppressant presented as an oral dosage form for systemic administration. It is used to manage autoimmune diseases such as rheumatoid arthritis and psoriasis, as well as to treat certain hematologic and solid‑tumor cancers in both adult and pediatric patients.

GNH USA supplies Methotrexate Orion Pharma as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, oncology centres and clinics worldwide under stringent quality standards and adhering to regulatory requirements.

Methotrexate is an antimetabolite that modulates immune activity and cell proliferation, making it useful in several disease categories.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin plaque formation and severity. - Acute lymphoblastic leukemia: inhibits leukemic cell proliferation and improves remission rates. - Other cancers (e.g., breast, lung): provides anti‑proliferative activity as part of combination chemotherapy.

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Fatigue - Mouth sores (stomatitis) - Elevated liver enzymes - Low blood cell counts (anemia, leukopenia, thrombocytopenia) - Hair thinning or loss

Serious or Rare Side Effects: - Severe liver toxicity (fibrosis or cirrhosis) - Pulmonary fibrosis or interstitial pneumonitis - Bone marrow failure (aplastic anemia) - Renal impairment or failure - Severe cutaneous reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis) - Opportunistic infections due to immunosuppression

Before initiating therapy, clinicians should assess baseline organ function and counsel patients on risk mitigation.

- Monitor liver function: perform baseline and periodic liver enzyme tests. - Assess renal function: evaluate creatinine clearance before and during therapy. - Check blood counts: conduct regular CBC to detect cytopenias. - Avoid in pregnancy: drug is contraindicated for women who are pregnant or may become pregnant. - Counsel on contraception: use effective contraception throughout treatment and for several months after discontinuation. - Store at below 25°C: keep in original container, protect from moisture and light.

Methotrexate interacts with several medicines that can alter its safety or efficacy.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Proton pump inhibitors (e.g., omeprazole): may raise serum methotrexate levels. - Live vaccines: heightened risk of infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Penicillins: may affect renal clearance of methotrexate. - Azathioprine: combined immunosuppression may increase infection risk. - Alcohol: potentiates liver toxicity.